v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating Activities:    
Net loss $ (300,161) $ (25,610)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Remeasurement of derivative instruments (27,260) 12,465
Stock-based compensation 16,957 18,425
Depreciation 13,293 12,441
Amortization of debt issuance costs 11,397 10,195
Amortization of intangible assets 8,656 8,615
Amortization of operating lease assets 7,762 4,377
Remeasurement of contingent consideration to fair value 3,709 272
Loss on investment revaluation - Ceribell, Inc. 3,622 0
Deferred income tax expense 2,763 5,556
Loss on debt extinguishment 2,651 25,482
Impairment of investment in ShiraTronics, Inc. 0 5,750
Other 968 704
Changes in operating assets and liabilities:    
Accounts receivable, net (13,672) 8,398
Inventories (6,038) (10,938)
Other current and non-current assets 35,540 (3,366)
Accounts payable and accrued current and non-current liabilities (33,171) (25,380)
Taxes payable (897) 820
SNIA environmental liability 362,070 0
Litigation provision liability (1,303) 5,131
Net cash provided by operating activities 86,886 53,337
Investing Activities:    
Purchases of property, plant, and equipment (25,937) (18,554)
Proceeds from investments 6,522 0
Other (181) (378)
Net cash used in investing activities (19,596) (18,932)
Financing Activities:    
Repayment of long-term debt obligations (210,250) (238,750)
Shares repurchased from employees for minimum tax withholding (3,881) (8,125)
Proceeds from long-term debt obligations 0 335,513
Payment of debt extinguishment costs 0 (38,953)
Purchase of capped calls 0 (31,637)
Proceeds from unwind of capped calls 0 22,523
Payment of contingent consideration 0 (13,750)
Payment of debt issuance costs 0 (5,698)
Proceeds from exercise of stock options 0 3,682
Other 728 472
Net cash (used in) provided by financing activities (213,403) 25,277
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 16,195 (4,433)
Net (decrease) increase in cash, cash equivalents, and restricted cash (129,918) 55,249
Cash, cash equivalents, and restricted cash at beginning of period 723,556 577,872
Cash, cash equivalents, and restricted cash at end of period $ 593,638 $ 633,121